Navigation Links
Alzheimer's Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimer's Disease
Date:2/11/2010

NEW YORK, Feb. 11 /PRNewswire-USNewswire/ -- The Alzheimer's Foundation of America (AFA) today applauded the Social Security Administration for including early-onset Alzheimer's disease among the medical conditions that will be given automatic approval for disability benefits, rather than have individuals go through what could be a lengthy qualification process.

"Every minute counts for people with Alzheimer's disease," said Eric J. Hall, AFA's president and chief executive officer. "By fast-tracking the process to obtain benefits, the Social Security Administration is assisting countless younger individuals with Alzheimer's disease and their families whose quality of life depends on this type of support. The Compassionate Allowance will make an enormous difference in enabling affected individuals to move toward managing their diagnosis and planning for the future."

Early-onset Alzheimer's disease is a rarer form of the brain disorder in which symptoms appear prior to age 65, even occurring in individuals in their 30's and 40's. More commonly, Alzheimer's disease affects individuals 65 and older.

Last September, in a comment letter to the Social Security Administration, AFA had pressed for fast-tracking in light of the significant number of individuals with early-onset Alzheimer's disease as well as the additional issues they often face due to their younger age. For example, AFA had noted, they are less likely to be diagnosed because healthcare providers generally don't look for this brain disorder in younger people; and many who are still employed when symptoms emerge are forced to give up work and other responsibilities due to their declining cognitive function.

In its announcement today, the Social Security Administration said that it is adding 38 conditions, including early-onset Alzheimer's disease, to its list of Compassionate Allowances—a  way of quickly identifying diseases and other medical conditions that clearly qualify for Social Security and Supplemental Security Income disability benefits. It allows the agency to electronically target and make speedy decisions for the most obviously disabled individuals. Electronic identification of the additional conditions begins March 1.

Social Security Commissioner Michael J. Astrue said the expansion means that "tens of thousands of Americans with devastating disabilities will now get approved for benefits in a matter of days rather than months and years."

The Alzheimer's Foundation of America is a nonprofit organization based in New York City that focuses on providing optimal care to individuals with Alzheimer's disease and related illnesses, and their families, and unites 1,200 member organizations nationwide that provide hands-on programs. AFA's services include a toll-free hot line with counseling by licensed social workers, a free caregiver magazine, a National Memory Screening Day initiative and the AFA Quilt to Remember.  For information, call 866-AFA-8484 or visit www.alzfdn.org.                                      

SOURCE Alzheimer's Foundation of America

RELATED LINKS
http://www.alzfdn.org/

'/>"/>

SOURCE Alzheimer's Foundation of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Autism Science Foundation Offers IMFAR Grants to Autism Stakeholders
3. Stuttering Foundation Hails New Research
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
6. National Patient Safety Foundation Leads Nationwide Effort to Promote Patient Safety
7. Arthur M. Blank Family Foundation Hosts Author of Last Child in the Woods: Saving our Children from Nature-Deficit Disorder
8. Autism Science Foundation Announces 2010 Doctoral Training Award Recipients
9. HSS Supports Arthritis Foundation Focus on Raising National Awareness of Osteoarthritis
10. Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Childrens Hospital
11. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: